Eli Lilly & Comapny | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Eli Lilly & Comapny

Sort by

Viewing results 1‒25 of 1031

Drugs research
Novo Nordisk and Eli Lilly set to face new challenger in weight-loss race
...Despite Novo Nordisk and Eli Lilly’s lead, Steensberg believed there was space for others to develop weight-loss products....
January 23, 2024
Biotech
Drugmakers race to find alternative suppliers as US cracks down on Chinese biotech
...Eli Lilly and Vertex declined to comment on the talks....
April 11, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Novo Nordisk AS
Novo Nordisk chief seeks more deals to cement weight-loss lead amid ‘hype’
...But the companies do not have a history of protein manufacturing used by Novo Nordisk and its US rival Eli Lilly to make their diabetes and weight-loss products....
March 8, 2024
News updates from April 17: UK inflation falls less than expected; Boeing engineer says safety concerns are ignored
Eli Lilly reports weight-loss drug ‘significantly’ reduces sleep apnoea
...Eli Lilly’s weight-loss drug tirzepatide significantly reduced sleep apnoea problems in a late-stage clinical trial, the pharmaceutical group said on Wednesday, adding to evidence that could encourage more...
April 17, 2024
Eli Lilly & Co
Eli Lilly weight-loss drug found to address sleep apnoea in trial
...Eli Lilly’s weight-loss drug tirzepatide significantly reduced sleep apnoea problems in a late-stage clinical trial, the pharmaceutical group said on Wednesday, adding to evidence that could encourage more...
April 17, 2024
News updates from March 12: US House votes through bill to ban TikTok; Geert Wilders announces he will not be Netherlands PM
Eli Lilly teams with Amazon to dispense Zepbound and other medication
...The push into prescriptions and drug delivery is unusual for a pharmaceutical manufacturer, pitting Eli Lilly against US pharmacy chains such as CVS and Walgreens. Read more here...
March 13, 2024
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
News updates from March 8: US adds 275,000 jobs in February; Bitcoin and gold touch new highs
US regulators delay decision on Eli Lilly’s Alzheimer’s drug
...US drug regulators have delayed a decision on whether to approve Eli Lilly’s breakthrough Alzheimer’s drug, which was expected to be greenlit this month, the drugmaker said on Friday....
March 8, 2024
Eli Lilly & Co
Eli Lilly strikes drug dispensing deal with Amazon
...The push into prescriptions and drug delivery is unusual for a pharmaceutical manufacturer, pitting Eli Lilly against pharmacies such as CVS and Walgreens....
March 13, 2024
Eli Lilly & Co
US regulator delays decision on Eli Lilly’s Alzheimer’s drug donanemab
...Patients on the donanemab study had more advanced Alzheimer’s than patients on similar studies, Eli Lilly said....
March 8, 2024
News updates from February 6: US court denies Trump presidential immunity, Boeing jet in Alaska Airlines blowout was missing bolts
Eli Lilly says diabetes and obesity drugs will boost sales by 20% this year
...Demand for a new class of diabetes and obesity drugs will boost US drugmaker Eli Lilly’s sales by 20 per cent in 2024, pushing its revenues above $40bn, the company said on Tuesday....
February 6, 2024
News in-depthEli Lilly & Co
Eli Lilly races to boost capacity as it rolls out rival to Novo Nordisk weight-loss drug
...BSP previously produced Covid antibody treatment bamlanivimab for Eli Lilly....
March 5, 2024
LexHelen Thomas
The Lex Newsletter: Living in an Ozempic world Premium content
...But that is what Eli Lilly did this week....
March 15, 2024
LexEli Lilly & Co
Eli Lilly’s heavyweight status looks set to last Premium content
...Eli Lilly was once considered something of an also-ran in the pharmaceutical industry....
January 16, 2024
Amazon.com
Amazon hopes anti-obesity drug demand will boost pharmacy business
...The retail giant struck a deal earlier this month to dispense medication on behalf of Zepbound maker Eli Lilly’s direct-to-consumer service LillyDirect....
March 26, 2024
Drugs research
Eli Lilly’s weight-loss drug set for UK launch ‘within weeks’
...It is also unlikely that Eli Lilly will provide enough doses of the drug to Britain to meet the demand for weight loss treatments....
January 25, 2024
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
News in-depthDrugs research
The race to develop the next generation of weight-loss drugs
...Developed respectively by Novo Nordisk and Eli Lilly, they are now being prescribed to millions of people....
April 1, 2024
Eli Lilly & Co
Eli Lilly calls for scrutiny of rival Novo Nordisk’s deal to expand production of weight-loss drug
...Eli Lilly has called for competition regulators to scrutinise an $11bn deal by its main competitor Novo Nordisk to snap up additional manufacturing capacity, as the rivalry between the drugmakers to dominate...
February 6, 2024
News updates from November 8: Iger pledges another $2bn in Disney cost cuts, Draghi delivers downbeat EU forecast
US approves Eli Lilly’s injectable weight loss drug
...The US federal drug regulator has approved Eli Lilly’s injectable diabetes medication for weight loss, as demand for the blockbuster treatments continues to surge....
November 8, 2023
Drugs research
Viking Therapeutics shares more than double on ‘statistically significant’ weight-loss trial results
...Eli Lilly’s share price fell as much as 2.4 per cent in early US trading before later recovering its losses....
February 27, 2024
News in-depthDementia
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
...Highlighting continued caution from regulators, the agency last month delayed an approval decision on donanemab, Eli Lilly’s Alzheimer’s drug....
April 22, 2024
News updates from November 2: Sam Bankman-Fried convicted, BoE leaves rates unchanged
Eli Lilly lowers earnings forecast due to acquisition-related costs
...Eli Lilly lowered its expectations for full-year earnings because of accounting charges related to recent acquisitions, despite beating expectations in the third quarter driven by growth in diabetes and...
November 2, 2023
Pharmaceuticals sector
Approval for Eli Lilly obesity drug sets up rival to Wegovy
...The side effects of Eli Lilly’s and Novo Nordisk’s obesity treatments are very similar, and patients could switch from one to the other, Stanford said....
November 9, 2023
Pharmaceuticals sector
Novo Nordisk and Eli Lilly hoover up smaller obesity drug groups
...“The obesity field is going to be dominated by those two guys [Novo Nordisk and Eli Lilly] and who wants to go up against them?” he said. “It would be super hard.”...
October 24, 2023
News updates from October 3: McCarthy ousted as House speaker, Japanese yen falls through 150 level
Eli Lilly doubles up to buy Point Biopharma for $1.4bn
...Eli Lilly has agreed to buy cancer biotech Point Biopharma for about $1.4bn, paying a premium of almost 90 per cent to Monday’s closing price amid a severe cash crunch in the biotech industry....
October 3, 2023
LexMergers & Acquisitions
Eli Lilly: Point acquisition gives battered biotech sector a boost Premium content
...Eli Lilly’s $12.50 a share cash offer for Point represents a 50 per cent premium to the stock’s undisturbed three month average....
October 3, 2023

Previous pagePage 1 of 42Next page